Survey Finds Mixed Funding Outlook Among Genomics Researchers | GenomeWeb

NEW YORK (GenomeWeb News) – While the outlook for genomics-related funding is modestly positive in the near-term, expectations turn progressively more negative moving forward, a survey conducted by investment firm Mizuho Securities in collaboration with GenomeWeb found.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.